This company listing is no longer active
MD Medical Group Investments Past Earnings Performance
Past criteria checks 1/6
Key information
18.1%
Earnings growth rate
18.1%
EPS growth rate
Healthcare Industry Growth | 12.6% |
Revenue growth rate | 14.8% |
Return on equity | 17.5% |
Net Margin | 18.1% |
Next Earnings Update | 11 Sep 2023 |
Revenue & Expenses BreakdownBeta
How MD Medical Group Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 25,222 | 4,560 | 3,513 | 0 |
30 Sep 22 | 25,296 | 4,486 | 3,547 | 0 |
30 Jun 22 | 25,370 | 4,412 | 3,581 | 0 |
31 Mar 22 | 25,295 | 5,208 | 3,492 | 0 |
31 Dec 21 | 25,220 | 6,003 | 3,402 | 0 |
30 Sep 21 | 24,194 | 5,705 | 3,264 | 0 |
30 Jun 21 | 23,169 | 5,407 | 3,126 | 0 |
31 Mar 21 | 21,151 | 4,802 | 2,966 | 0 |
31 Dec 20 | 19,133 | 4,196 | 2,807 | 0 |
30 Sep 20 | 17,721 | 3,535 | 2,723 | 0 |
30 Jun 20 | 16,309 | 2,874 | 2,639 | 0 |
31 Mar 20 | 16,234 | 2,756 | 2,640 | 0 |
31 Dec 19 | 16,160 | 2,638 | 2,641 | 0 |
30 Sep 19 | 15,896 | 2,672 | 2,620 | 0 |
30 Jun 19 | 15,631 | 2,707 | 2,599 | 0 |
31 Mar 19 | 15,284 | 2,689 | 2,566 | 0 |
31 Dec 18 | 14,937 | 2,671 | 2,533 | 0 |
30 Sep 18 | 14,603 | 2,587 | 2,454 | 0 |
30 Jun 18 | 14,268 | 2,502 | 2,374 | 0 |
31 Mar 18 | 14,012 | 2,496 | 2,314 | 0 |
31 Dec 17 | 13,755 | 2,489 | 2,254 | 0 |
30 Sep 17 | 13,369 | 2,392 | 2,198 | 0 |
30 Jun 17 | 12,982 | 2,296 | 2,141 | 0 |
31 Mar 17 | 12,581 | 2,181 | 2,104 | 0 |
31 Dec 16 | 12,179 | 2,066 | 2,067 | 0 |
30 Sep 16 | 11,491 | 1,939 | 2,006 | 0 |
30 Jun 16 | 10,803 | 1,813 | 1,944 | 0 |
Quality Earnings: MDMG has a large one-off loss of RUB1.3B impacting its last 12 months of financial results to December 31 2022.
Growing Profit Margin: MDMG's current net profit margins (18.1%) are lower than last year (23.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDMG's earnings have grown by 18.1% per year over the past 5 years.
Accelerating Growth: MDMG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MDMG had negative earnings growth (-24%) over the past year, making it difficult to compare to the Healthcare industry average (-25.9%).
Return on Equity
High ROE: MDMG's Return on Equity (17.5%) is considered low.